chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Situation 2/21/1962 Patient is here for first dose of covid vaccination Background  History of hypertension Assessment Pt has completed a 60 minute-minute observation period with the following signs and symptoms of an adverse reaction: other - chest pain/pressure and throat numbness and flushing. Pfizer-BioNTech COVID-19 vaccine #1 in series administered.  Action(s) taken: Other - Vital signs, MD evaluation, O2 2lnc Allergy to COVID-19 vaccine documented in Allergies activity: Yes Patient advised to discuss second dose considerations with a clinician  1339:  Patient awake, alert, ambulatory, reporting mid chest pressure 8/10, and throat feeling "different," pt fanning herself and feeling hot.  Denies SOB, nausea, dizziness, palpitations or any other symptoms.   1340:  Pt taken to procedure.  Pt is able to speak in full sentences. VS taken BP 174/106 HR 77 SpO2 97% RA RR 20.  No angio edema, no rash, no reports of itching, BS clear to auscultation.   Denies history of anxiety and states she has never had this pain before.  Does report feeling nervous prior to getting vaccinated.  Pt reports hx of HTN which she takes lisinopril 1/2 tab daily (she took today's dose), pt did not know dosage.  1342:  BP recheck 172/99 HR 80.  1346:  I have called Dr., incident to for the covid vaccine clinic, and given report.  Received VO to transport pt to ER via ALS, read back completed.   1350:  Pt now reporting pain is traveling to abdomen and is intermittent. Dr. notified.  Received VO to administer O2 2lcn and aspirin 325 mg PO x 1 now.  Readback completed.   1400:  Pt is agreeable to being transported to ER via ambulance.  Pt also reported she had taken aspirin this morning, she did not know the dose.  Dr. notified and ordered to hold aspirin 325 mg PO x 1, read back completed.  Pt placed on O2 2lnc.   1411:  Called to request ambulance transportation to Hospital.   1414:  Pt denies any chest pain or any other symptoms.  BP 157/105 HR 78 SpO2 97% RA Recommendation/Action: 1440:  Paramedics have arrived.  Report given. While report was being given to paramedics pt stated she started having the chest pain 5 minutes after vaccine was administered and reported it 14 minutes after vaccine administration.
(2 week after vaccination ) (Right arm) tingling which runs down into the ring and pinky fingers; (2 week after vaccination ) (Right arm) numbness; (2 week after vaccination ) (Right arm) muscle spasms; (2 week after vaccination ) (Right arm) stiffness; Soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness at injection site), PARAESTHESIA ((2 week after vaccination ) (Right arm) tingling which runs down into the ring and pinky fingers), HYPOAESTHESIA ((2 week after vaccination ) (Right arm) numbness), MUSCLE SPASMS ((2 week after vaccination ) (Right arm) muscle spasms) and MUSCULOSKELETAL STIFFNESS ((2 week after vaccination ) (Right arm) stiffness) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced VACCINATION SITE PAIN (Soreness at injection site). On 20-May-2021, the patient experienced PARAESTHESIA ((2 week after vaccination ) (Right arm) tingling which runs down into the ring and pinky fingers), HYPOAESTHESIA ((2 week after vaccination ) (Right arm) numbness), MUSCLE SPASMS ((2 week after vaccination ) (Right arm) muscle spasms) and MUSCULOSKELETAL STIFFNESS ((2 week after vaccination ) (Right arm) stiffness). At the time of the report, VACCINATION SITE PAIN (Soreness at injection site), PARAESTHESIA ((2 week after vaccination ) (Right arm) tingling which runs down into the ring and pinky fingers), HYPOAESTHESIA ((2 week after vaccination ) (Right arm) numbness), MUSCLE SPASMS ((2 week after vaccination ) (Right arm) muscle spasms) and MUSCULOSKELETAL STIFFNESS ((2 week after vaccination ) (Right arm) stiffness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication history not provided.  Treatment information was unknown.
Severe headache lasting more than two weeks. After 3 days I went to the emergency room. I went due to a number of symptoms(fever, chills, nausea, severe body aches, neck stiffness, blurred vision) the headache was my chief complaint and thought to be the cause of the other issues. My heart rate upon arrival was 223 causing me to be hooked up to a cardiac monitor, and my blood pressure was 72/56. I was swabbed for the flu and Covid. Both resulted negative. All labs blood and urine were normal. X-ray or chest was done and showed all clear. CT scan was also done and to my knowledge was clear. I was told I needed to get a lumbar puncture to check for meningitis because it was the only other thing they could think of. Upon doing the lumbar puncture CSF gushed from the needle used to puncture and my headache was gone within minutes. I was diagnosed with pseudotumor cerebri. Thought to be caused by my IUD. After going to see my OBGYN I was informed that my COVID vaccine had caused my IUD to release and unusual amount of hormones and that?s what caused the excess buildup of spinal fluid in my brain. I?m still, almost two months later experiencing headaches and back/neck pain. My IUD is still not working properly and is scheduled to be removed temporarily.
pt recv vax; inc T 104.7;apap & tepid bath given; fever came down then started rising again;to er; MD feels inc T probably due to vax;
Had the chills later that evening. Right Arm became sore, red and swollen. Having difficulty lifting Rt. arm up. Rt. arm is warm and tender to touch. Area is red and firm to Rt. Deltido. Also C/O pain and tenderness to Rt. Axillia and Rt. Breast are.
This client received a dose of Pfizer on 9/27/21, after having already received a dose on J&J on 4/2/21 unbeknownst to the vaccinator.
Onset of acute optic neuritis OD, worse following 2nd inoculation with symptoms of headache and orbital pain and marked visual field defect with loss of VA-OD to 20/40. Symptoms resolved and VA/VF returned to normal following IV steroids. Final dx: acute (immune) demyelinating encephalomyelitis (ADEM)
This is a spontaneous report from a contactable consumer or other non-HCP (patient). A 42-year-old (non-pregnant) female patient received the 2nd dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, formulation solution for injection, batch/lot# EW0151), age at vaccination of 42, via an unspecified route of administration, right arm, single dose, on Apr 15, 2021, at 11:15 am; and dose 1, (batch/lot# ER8732), on Mar 25, 2021, at 11:45 am, single dose, for COVID-19 immunization. The patient's medical history and concomitant medications not reported. Reportedly, no COVID-19 prior vaccination. The patient has not tested for COVID-19 post vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered: Doctor's office/urgent care. On Apr 15, 2021, at 11:30 pm, patient experienced 102 fever, chills and body aches. Therapeutic measures were taken with Advil, as a result of the adverse events. The clinical outcome of the events: not recovered. No follow-up attempts needed. No further information expected.
Within 5 min of 2nd vaccine (flu) pt stated she didn't feel good. Passed out in chair. Shaking, eyes rolling approximately 1 min. When cane too, c/o not being able to hear or see.
Local reaction (right posterior upper arm) with circular raised erythematous firm and warm rash, non-tender, approximately 5cm in diameter, developed over first 24 hours after vaccine administration.
P/vax pt exp cellulitis of upper right arm over deltoid area,erythema,induration & increased edema & warmth.Size of rxn 10cm x 5cm. Pt had not had dose of TD in last 10 yr.
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low-grade fever) and MYALGIA (muscle aches) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023C21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy and Heart block. Concomitant products included ATENOLOL, AMLODIPINE and ENALAPRIL for Hypertension, CLOPIDOGREL and ACETYLSALICYLIC ACID (BAYER ASPIRIN) for an unknown indication. On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, the patient experienced PYREXIA (Low-grade fever) and MYALGIA (muscle aches). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PYREXIA (Low-grade fever) and MYALGIA (muscle aches) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
11:45 W/in 5 minutes upon receiving Varivax pt experienced itching, swelling and redness at the injection site. Reddened area was about 3 CM, raised and swollen. Gave her Benadryl 50 mg PO at 11:50. Decreased swelling are at site. EMS here at 11:50 no transport
Started running fever 4-5 hrs after flu shot administered.  On about day 2 went to ER & Dr there thought fever related to flu shot.  No other s/s noted.  Child slept a lot of next few days.  Ran 104 temp x4 days total.
8/2/21: She had been feeling sick for the last 4-5 days and tested positive for COVID-19 on 7/28/2021. She was brought to the emergency room department on 8/2/2021 for further symptoms of body aches, myalgias and headaches.  She was found to be hypoxemic and required oxygen supplementation.   8/4/21: discharged home with O2 monitoring kit  Note: Pfizer COVID-19 Vaccine received 03/16/2021 and 04/06/2021.
This spontaneous report as received from a medical assistant (also reported as health care worker) refers to a male patient of unknown age. The patient's medical history included Asperger syndrome and attention deficit hyperactivity disorder. On 21-NOV-2012 the patient was vaccinated with GARDASIL dose 1 (lot # H013831 and expiry date 6-MAR-2015), 0.5 ml, via intramuscular route in the left arm. Other co-suspects and concomitant medication were not reported. On an unknown date the patient experienced dizziness on receiving dose 1 of GARDASIL while in the office. He was kept in the office for 30 minutes for observation and then was sent home. When he went home he experienced nausea and vomiting. There was no fever and diarrhea. He recovered 3 days later. The parent of the patient did not seek medical attention for the vomiting and nausea and only recently mentioned to the office what had happened. Also reported that the patient will not be receiving further doses of GARDASIL. Cancer and overdose was not reported. The outcome of dizziness, nausea and vomiting was reported as recovered/resolved. Causality was not specified by the reporter. Additional information has been requested.
, Patient 8 months post last COVID-19 vaccine.  Patient sustained vaccine injury (ongoing) to right shoulder (SIRVA) that may result in permanent disability. Patient unaware if vaccine injury reported to VARES.  Vaccine injury is SIRVA.  The injury is described as follows:  shoulder pain constant and described as a needle pain in his muscle all the time.  This pain increases with movement across the body and when he put it behind his back.   Patient reports some loss of functioning in his right arm.  Patient has seen several MDs with no improvement.   Pain constantly to 2-3 and increases to 6-7 upon movements described above.   MRI for further evaluation scheduled for 12/21.
Vaccine administered 13:54, adverse event started 13:55 same day. Patient had syncopy, flushing/sweating. BP 115/72 -- > 101/67 -- > 110/78, HR 64 -- > 58 -- > 60, O2=100% -> 97% -- > 98%, RR = 16, Temp 95.1F -- > 96.6F -- > 97.3F. At 15:01, Patient stated no longer lightheaded, patient stable, released from vaccination site.
PATIENT EXPERIENCED WEAKNESS AND FATIGUE DAY AFTER VACCINATION. SHE IS KEEPING HYDRATED AND WILL TAKE A APAP IF NEEDED
Swelling in the lymph node below her armpit and breast. Very sore to the touch.
Received flu vaccine on 11/22/00. Complained of chills, fever, night sweats, nausea and vomiting and fatigue on 11/24/00. On 11/27/00, had 10 lb weight loss, with increasing symptoms including diarrhea. Admitted to hospital on 11/27/00. Severe anemia. Pt was transferred to another facility.
Day 1 left arm sore and sore throat Day  2 Sore arm  hit at injection. left arm with lymph node swelling fever  breathing wheezing  and difficulties when lying down continuous coughing clearing of a very dry throat. Raspy voice, Fast heart rate 98, Headache all day  1 and 2; Ache all over joints ribs and back pain
Local erythema, local edema (moderate), warmth, mild pain to touch, at this time. Pt given prednisone 5 mg B.I.D. x 3 days per physician orders.
Moderna COVID-19 Vaccine  1st dose symptoms tiredness. 2nd dose symptoms began approx. 12 hours later from dose given. Began with severe headache for 2 hours turning into headache with chills and felt feverish. Woke in morning at 6 am. Could barely walk due to muscle/joint aches and exhaustion. Taste also felt funny. Fever of 99.9 around 2 pm. All symptoms felt severe and I stayed in bed all day. Everytime I  stood, I thought I'd fall down from weakness and sore muscles. By 10 pm, I went to sleep with same symptoms. Advil took the edge off. By the next morning, headache and aches gone, except my back feels like it is going to go out-had to wear my back brace. Severe exhaustion-when I stood I thought I would pass out. Dizzy and weak, mild headache, not very hungry all day. By 9 pm felt less weak. By 6 am next day, symptoms seemed to have disappeared except for my back pain.
FATIGUE; HEADACHE; FEVER; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included breastfeeding, and psoriasis. The patient experienced drug allergy when treated with doxycycline, and tetracycline. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 0242A21A expiry: UNKNOWN) dose was not reported, administered on 06-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 06-APR-2021, the subject experienced fatigue. On 06-APR-2021, the subject experienced headache. On 06-APR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 103.8 F, and Pain scale (NR: not provided) 06/10 (unit not reported). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fatigue on 08-APR-2021, headache on 13-APR-2021, and fever on 07-APR-2021. This report was non-serious. This parent/child case is linked to 20210531484.; Sender's Comments: V0-Medical Assessment Comment not required as per standard operating procedures, as case was assessed as non-serious.
Woke up in middle of night with headache, chills, muscle aches, a bit nauseous.  These symptoms were worse than I have experienced for other vaccines ( for example flu vaccines).  I could not get back to sleep, so I took 2 tylenol, still could not sleep, and symptoms persisted all day and next night.  I took 2 tylenol everey 8 hours , and finally tried taking 2 advil also in the evening.  The Advil seemed to help some to relieve chills and headache.  I got some sleep that night.  The next morning 8/11/2019 was the first time in over 24 hours that I felt good enough to get up and eat normally and start to resume normal activities.  By noon, I was feeling much better,  and I hadn?t taken Tylenol or Advil for 12 hours.  My Arm is still sore ate injection site, but I am fine now.
The client received the COVID vaccine Pfizer for 5 through 11 years of age (Lot# FL0007 exp: 05/31/22) at 11:03AM. RN noted the client was 15 years old after administration of the COVID vaccine Pfizer for 5 through 11 years of age. RN provided education stating the client received the incorrect formulation of the COVID vaccine Pfizer. RN educated client on possible adverse reactions and when to seek medical care. The client denied any chronic conditions, current medications, or known allergies. The client stated she weighs 55 kilograms. Consulting MD recommended against repeat vaccination today, but stated in 21 days the client may receive a dose of COVID vaccine Pfizer for 12 years of age and older at the parent's request.
I called to see if vaccine will be effect and I was told no So she will need 3 more injections (this was her first); Patient received GARDASIL 9 in the tricep muscle instead of the deltoid muscle; Information has been received from a nurse practitioner referring to a patient of unknown age and gender. The patient's medical history, current conditions and concomitant medications were not reported.  On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis (strength, dose, units, lot# and expiration date unknown) intramuscularly in the triceps muscle instead of deltoid muscle (product administered at inappropriate site). No adverse effects were reported.   Follow up information has been received from the nurse practitioner on 10-JUL-2019. The patient was 17 years old female. The patient had none illness at time of vaccination, none pre-existing physician-diagnosed allergies, birth defects, medical conditions (specify) or adverse event following a prior vaccination. On 26-JUN-2019, the patient's first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) (lot# R004689 has been verified to be a valid lot number for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast), expiration date not reported, but upon internal validation established as 29-NOV-2020) was given in the left triceps muscle by a medical assistant instead of deltoid muscle where it should have been given. The nurse practitioner called to see if vaccine would be effective and was told no (drug ineffective) and so, the patient would need 3 more injection. The patient had no other adverse reaction. Prescription drug treatment for the event was not required. The outcome of drug ineffective was unknown (contradiction information: also reported as recovered). The causality assessment was no provided.
Patient had potential allergic reaction to second dose of Moderna vaccine. She stated no issues to first dose and answered no to all patient screening questions. Approximately 10 minutes after administering the dose, the patient complained of a painful tongue, which she was instructed to stay for further monitoring. After 15 minutes, the patient stated that she felt like her tongue was swollen and stating her tongue felt dry. Patient also noted at this time that she has had a reaction similar to this previously with other vaccines (Metallic taste) and to Zanaflex (Swollen tongue). Before vaccine given, noted patient did not mention previous issues or adverse reactions to vaccines or medications, tolerated 1st dose of Moderna. Was given oral liquid Benadryl 25mg. Checked back with patient 15 minutes after giving Benadryl, which the patient felt it was better and not progressing. No issues breathing during event. Advised to follow up with provider if continues, continue Benadryl as needed and monitor severe allergic reactions.
Pt complaining of shoulder pain since receiving FLUZONE vaccine. Sought help/seen Dr 11/6/12.
On Friday the 26th they gave her the vaccine and on Saturday she started with a small headache it continued on Sunday and on Monday she collapsed around 5pm 911 was called where she is still in critical condition with a cerebral aneurysm. She has never had to visit the hospital for anything the doctor gave me absurd responses. I need a reasonable one.
While at rest heart rate rose to over 170 bpm  and it became extremely difficult to breathe. The worst lasted about 15 minutes but tachycardia lasted hours.
Arm soreness, redness, skin warm to the touch until end of day 2(12/24/2020). Day 7(12/30/2020), itching started. Shortly after, redness, knot, warm to the touch. Redness continued to spread until day 14(1/6/2021) and slowly returned to normal over the following two days(1/7/2021-1/8/2021). Redness was marked with marker on 12/31/2020 to monitor spreading.
Had a dry cough, the next day had a headache, back ache and congestion. Took a home COVID-19 test and was positive. Contacted doctor and decided not to take any medication for it.
Injection site  area is swollen; This is a spontaneous report from a contactable consumer or other non hcp. A male patient of an unspecified age received BNT162B2 (formulation: Solution for injection, Lot Number: EW0165, Expiration Date: 31Aug2021), via an unspecified route of administration on 10Aug2021 as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. The patient experienced injection site area is swollen (vaccination site swelling) on 10Aug2021. The reporter stated that their husband had the shot (Further clarified as COVID 19 Vaccine) on the 10th (Further clarification unknown) and he was just showing that Injection site area is swollen.  The clinical outcome of the event was unknown.  Reporter was unwilling to share further information. Hence further probing could not be done. Limited information available over the call.
Within 6 hours after vaccinations the patient's left arm was warm, with severe pain and difficulty raising her arm. The patient was treated with heat and Tylenol.
first dose administered 41 days ago 4May2021; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (first dose administered 41 days ago 4May2021) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (first dose administered 41 days ago 4May2021). On 04-May-2021, PRODUCT DOSE OMISSION ISSUE (first dose administered 41 days ago 4May2021) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. Treatment information not reported.   Reporter did not allow further contact
12 cm longitudinal x 9.5 cm horizontal red warm slightly tender area left deltoid with central blanched area and slightly to the left of that is a small fluid-filled blister.
Patient consent to second booster of Moderna in Covid clinic, Answered questions before administration and verified dosage and patient. Patient provides vaccination card with 3 series doses of Moderna visible on card. After administration patient agreed with wife explaining to me that Pharmacy accidently gave the 4th dose of pfizer on 11-12-2021 but patient appointment was for Flu vaccine at Pharmacy on that day. Patient state the nurse explain to them that they was given the wrong shot. Patient stated he was good with that being they was given 3rd dose 2wks prior. I explained to patient that this shot administered today was actually 5th dose instead of 4th dose. Patient states he will not need anymore, and we good extra vaccinated. Patient was monitored for 15 minutes, no adverse reactions noted.
Post vax, the patient's thigh became swollen, with a large area of induration, warmth and mild pain.
death J18.9 - Pneumonia, unspecified organism J96.01 - Acute respiratory failure with hypoxia
high fever, rapid heart rate, nausea, diarrhea, dizzines, weakness, body aches